Pharmacokinetics

Phase 1Small molecule

Pfizer

Pharmacokinetics is one of 9 small molecule programs targeting CLE. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CLENot yet recruiting

CLEPhase 1

Not yet recruiting

Competition

Competitive Landscape

13 competitors in CLE

#DrugCompanyPhaseTrials

Zytiga

Johnson & Johnson

Phase 3

1 2

Zuragard

ZZurex Pharma, Inc.

Phase 2

1 3

Keto Acid

UUniversity Hospital, Clermont-Ferrand

Phase 3

1 4

Brethine

Sanofi

Preclinical

2 5

Povidine-Iodine

MMidAtlantic Retina

Phase 2

1 6

Clenbuterol

UUniversity of Copenhagen

Preclinical

1 7

Pharmacokinetics

Pfizer

Phase 1

1 8

Triptorelin Acetate

Ipsen

Preclinical

1 9

Recombinant Hcg

UUniversitair Ziekenhuis Brussel

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Oral1 trial

Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State

Completed· Pfizer logo

Pfizer·Phase 1·NCT00861458·14 enrolled

CLE1 trial

Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance

Not yet recruiting·—·Phase 1·NCT05136963·48 enrolled

Critically Ill1 trial

Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)

Unknown status·RRadboud University Medical Center··NCT03248349·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Pharmacokinetics. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacokinetics compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacokinetics. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Pfizer

Pharmacokinetics

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Oral1 trial

CLE1 trial

Critically Ill1 trial

References

Drug Info

Quick Facts

Related News